BioSpace News Archive

On Track to Initiate Three Clinical Trials in 2021 Across Franchise of Targeted Hematology Therapies, Including Phase 3 Trial for SY-1425 in MDS

Receives additional EU Patent for the Pure-Vu® System that protects the design of its fecal waste evacuation channels

In line with the need for pharmaceutical research, cell and gene therapy, vaccine production and biobanking laboratories for dependable sample protection, the new series of controlled-rate freezers from Thermo Fisher Scientific provides precise, repeatable freezing capabilities, while enhancing data traceability to support GMP and 21 CFR part 11 requirements.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced that it has entered into a Securities Purchase Agreement pursuant to which MediciNova has agreed to issue US$20 million in shares of its common stock to 3D Opportunity Master Fund, a fund managed by 3D Investment Partners Pte.

Indiana University School of Medicine and Regenstrief Institute research scientists have received a $3.4 million award from the Patient-Centered Outcomes Research Institute (PCORI) to investigate the best care options for the 40 percent of people who go to the hospital emergency department with chest pain that is determined to be caused by anxiety rather than a cardiac event.

Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, announced the pricing of its initial public offering of 5,000,000 ordinary shares at a public offering price of US$5.00 per share.

Rising healthcare spending, increasing cancer cases, growing elderly population, and adoption of automated systems are the vital factors driving the growth of global tissue diagnostics market.

The Center for Organ Recovery & Education announced that 2020 was the second record-breaking year in a row for Saving and Healing lives through organ, tissue and cornea donation in western Pennsylvania and West Virginia.

Growing elderly population is primarily driving the growth of global IVD (in vitro diagnostics) market. As per United Nations (UN), there were over 962 million people aged above 60 years across the globe in 2017.

Factors such as mounting costs of on-site radiologists, increasing adoption of teleradiology services across healthcare facilities for enhanced patient care, and rising prevalence of chronic ailments such as congestive heart failure as well as breast cancer are augmenting the growth of global teleradiology market.